Filed before 2025Filed 14 November 2023
Hemoshear Therapeutics, Inc. raised $3.5M
Hemoshear Therapeutics, Inc., a biotech company based in Charlottesville, VA, raised $3.5M in a new debt round, according to a filing dated 14 November 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 14 November 2023
- Round
- Debt round
- Amount sold
- $3.5M
- Offering size
- $8M
- Investors so far
- 4
- Based in
- Charlottesville, VA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 34% of the 1,396 tracked raises with an amount filed in 2023, and than 32% of the 142 in biotech.
Hemoshear Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 14 Nov 2023 | New filing | $3.5M | This raise |
| 18 Feb 2021 | New filing | $43.1M | Another raise |
More with Panther Micro on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.